Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03588494

Unknown

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Quality of Life
NCT01223235

Completed

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Ovarian Cancer | Peritoneal Cancer | Fallopian Tubes Cancer
NCT02157103

Completed

A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma

Glioblastoma
NCT03468296

Unknown

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept (TRISTAR)

Neovascular Age-related Macular Degeneration
NCT03404037

Completed

Serum Endostatin Type 2 Diabetic Patients

Coronary Artery Disease | Diabetes Mellitus, Type 2 | Coronary Arteriosclerosis
NCT01863199

Completed

Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD) (Liberty)

Neovascular Age Related Macular Degeneration
NCT02513862

Completed

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

C.Surgical Procedure; Cardiac
NCT02747823

Unknown

PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (CBT124NHV001)

Healthy
NCT02525536

Completed

A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors

Neoplasms, Advanced Solid
NCT02296567

Unknown

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

Age Related Macular Degeneration
NCT01271283

Withdrawn

Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
NCT00964795

Completed

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Neovascular Age-related Macular Degeneration
NCT00193492

Completed

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

Lymphoma, Follicular
NCT01464671

Terminated

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

Coronary Artery Disease
NCT00881504

Terminated

A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Biliary Tract Cancer
NCT00992563

Completed

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

Age Related Macular Degeneration
NCT00387582

Completed

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema
NCT00708435

Completed

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Blood Coagulation Disorders | Acute Major Bleeding
NCT00417768

Terminated

Safety and Effectiveness of tPA in Intra-abdominal Abscesses

Abscess
NCT00264381

Completed

Management of Superficial Thrombophlebitis

Superficial Thrombophlebitis | Upper Extremity Superficial Thrombophlebitis | Lower Extremity Superficial Thrombophlebitis
NCT01014468

Unknown

Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration (AxL-2009)

Age Related Macular Degeneration
NCT00777504

Unknown

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Renal Cell Carcinoma | Gastrointestinal Stromal Tumor
NCT00083577

Completed

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Multiple Myeloma
NCT00162760

Completed

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

Idiopathic Pulmonary Fibrosis (IPF)
NCT00001524

Completed

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

Acquired Immunodeficiency Syndrome | HIV Infection | Burning Mouth Syndrome
NCT00002104

Completed

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

HIV Infections | Mycobacterium Avium-Intracellulare Infection | Tuberculosis, Mycobacterium Infection
NCT00002174

Completed

Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

HIV Infections
NCT06881628

Recruiting

Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients

Cirrhosis | Variceal Bleeding | Upper Gastrointestinal Bleeding (UGIB)
NCT06845163

Recruiting

Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema (DAPA-DME)

Diabetic Macular Edema | Center-involved Diabetic Macular Edema
NCT06550453

Recruiting

Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

Locally Advanced Colorectal Cancer
NCT06182800

Not yet recruiting

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Non-small Cell Lung Cancer
NCT05931328

Recruiting

The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.

Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
NCT05909072

Not yet recruiting

Tranexamic Acid With Microneedling in Melasma

Melasma
NCT05654454

Recruiting

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer
NCT05440578

Not yet recruiting

First-line Olaparib Combined With Bevacizumab Maintenance Therapy

Ovarian Neoplasms
NCT04613284

Not yet recruiting

Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC (RELIEF)

Lung Cancer
NCT04262687

Recruiting

Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate (POCHI)

Colorectal Cancer Metastatic | Microsatellite Stable | High Immune Infiltrate
NCT07432152

Enrolling by invitation

Developing a Community Support Program to Help People Quit Smoking.

Smoking Cessation
NCT07034560

Active, not recruiting

Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma (TXA-MELA)

Recurrence | Melasma | Treatment Outcome
NCT02230176

Completed

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II (OCCLURANDOM)

Pancreatic Neuroendocrine Carcinoma
NCT00309998

Completed

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT00028990

Completed

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer
NCT05410301

Withdrawn

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Glioblastoma | Recurrent Glioblastoma
NCT04872582

Active, not recruiting

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

Chemotherapy Effect | Metastatic Nasopharyngeal Carcinoma
NCT03035630

Withdrawn

Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma

Kidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney Carcinoma
NCT03037736

Withdrawn

Outpatient Performed Pterygium Surgery Study (OPPS)

Pterygium of Conjunctiva and Cornea
NCT03777254

Completed

Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration
NCT00436215

Completed

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Neoplasm
NCT00536939

Terminated

Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

Breast Cancer
NCT01013285

Completed

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Brain and Central Nervous System Tumors

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations